|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Sector | Acquiring Party | Transferring Party |
|---|---|---|
| Biopharmaceuticals | Genzyme Corporation (NASDAQ: GENZ ) | AnorMED, Inc. (AMEX: AOM ; TSX: AOM ) |
| Brings Genzyme a leading late-stage product candidate in development for hematopoietic stem cell transplantation. Deal value - $380m. A hostile more... | ||
| Biopharmaceuticals | Gilead Sciences, Inc. (NASDAQ: GILD) | Corus Pharma |
| Enables Gilead to help Corus more rapidly develop aztreonam lysine, an inhaled antibiotic to prevent lung infections in patients with cystic more... | ||
| Biopharmaceuticals | Inyx, Inc. (OTC Bulletin Board: IYXI) | Pharmapac UK Ltd. |
| Complements Inyx's pending acquisition of a pharmaceutical production business based in Germany, which will further strengthen Inyx's more... | ||
| Biopharmaceuticals | Leman Cardiovascular SA | Hancock Jaffe Laboratories |
| Provides technology rights to Leman for tissue processing that has proven successful in heart valve manufacture. Terms not more... | ||
| Biopharmaceuticals | Merck KGaA | Serono SA |
| Creates a strategic combination with the size to better compete with the larger pharmaceutical companies. Enhances capabilities especially in more... | ||
| Biopharmaceuticals | Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) | AnorMED, Inc. (Nasdaq: ANOR; TSX: AOM) |
| Strategic fit with Millennium's focus on hematology-oncology, where its product VELCADE leads the market in treating patients with relapsed more... | ||
| Biopharmaceuticals | Mylan Laboratories Inc. (NYSE: MYL) | Matrix Laboratories Ltd. (Mumbai Stock Exchange) |
| Provides a global platform and expansion of dosage forms and therapeutic categories, as well as deepening Mylan's vertical integration and supply more... | ||
| Biopharmaceuticals | Nycomed Holdings | ALTANA Pharma AG (NYSE:AAA; FWB:ALT)(GER:ALT) |
| Nycomed’s product portfolio and pipeline will benefit from ALTANA Pharma’s marketing strength in key European markets. The combined group more... | ||
| Biopharmaceuticals | Omeros Corporation | Nura, Inc. |
| Expands the research capabilities and development of future products for Omeros, which is advancing a pipeline of pharmaceuticals and delivery more... | ||
| Biopharmaceuticals | Receptor BioLogix, Inc. | Late-Stage Cancer Drug Insegia™ from Aphton Corp. (Pink Sheet: APHTQ) |
| Fits well with Receptor's product development programs; a principal mechanism of gastrin tumor promotion is likely mediated through a member of more... | ||
| Biopharmaceuticals | UCB SA (UCBBt.BR) | Schwarz Pharma AG (SRZG.DE) |
| Broadens UCB's business and significantly enhances the commercial prospects of its late-stage development pipeline, global position in neurology more... | ||
| Data Management/ Healthcare IT | Cardinal Health, Inc. (NYSE: CAH) | MedMined, Inc. |
| Extends Cardinal Health's portfolio of patient safety solutions of hospital-acquired infections. Terms not more... | ||
| Data Management/ Healthcare IT | CareTech Solutions | Sabre Consulting |
| Strengthens CareTech's product range, development capabilities and further investment into web-based products software solutions. Terms not more... | ||
| Data Management/ Healthcare IT | Emergis Inc. (TSX: EME) | DINMAR Consulting Inc |
| Provides Emergis with an EHR solution for hospitals, integrating patient data from different clinical information system. Deal price -- $32m more... | ||
| Dental | Healthpoint Capital, LLC | DTI Dental Technologies Inc. |
| Together with its BioHorizons deal, provides a new high growth platform -- the dental laboratory industry attracting the public's increasing more... | ||
| Diagnostics | Bayer Diabetes Care, a unit of the Bayer Group (NYSE: BAY) | Metrika Inc. |
| Complements Bayer's portfolio to include a full spectrum of products for diabetes diagnosis and management. Terms not more... | ||
| Diagnostics | Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) | GeneDx Inc. |
| GeneDx is the country's leading laboratory for the diagnosis of complex genetic disorders. Deal value with contingent payouts - $17m. GeneDx more... | ||
| Diagnostics | Cardinal Health, Inc. (NYSE: CAH) | Five PET facilities from Regional Nuclear Pharmaceuticals |
| Cardinal distributed the radiopharmaceutical used in PET diagnostic imaging, but will now control the manufacturing process. Terms not more... | ||
| Diagnostics | Celsis International plc | In Vitro Technologies, Inc. |
| Complementary fit with existing Celsis businesses through improved product and services portfolios and cross-selling opportunities. Deal price - $30m more... | ||
| Diagnostics | Invitrogen Corp. (NASDAQ:IVGN) | Sentigen Holding Corp. (NASDAQ:SGHL) |
| Invitrogen buying Sentigen primarily for its protein-receptor screening system. Deal value - $25.9m; Sentigen's sales are about $4m, with more... | ||
| Diagnostics | PerkinElmer, Inc. (NYSE: PKI) | J.N. Macri Technologies LLC and NTD Laboratories, Inc. |
| Builds a comprehensive screening and diagnostics capability in maternal health by providing a leading position in free Beta hCG measurement in the more... | ||
| Diagnostics | Quest Diagnostics Incorporated (NYSE: DGX) | Focus Diagnostics, Inc. |
| Strengthens Quest's position as a provider of infectious and immunologic disease diagnostics to hospitals and physicians by adding Focus' more... | ||
| Diagnostics | Quest Diagnostics Incorporated (NYSE: DGX) | Enterix, Inc. |
| The acquried tests offer several important benefits over traditional guaiac-based fecal occult blood testing. Deal value -- approximately more... | ||
| Diagnostics | Siemens Medical Solutions (NYSE: SI) | Diagnostic Products Corporation |
| Furthers Siemens' objective to enable early in vitro diagnosis and individualized patient therapy, as a forward move complementing its imaging more... | ||
| Diagnostics | Ventana Medical Systems, Inc. | Vision Systems Limited |
| Creates a leading global supplier of solutions spanning the anatomical pathology environment. Complementary sales and support infrastructure. Vision more... | ||
| Diagnostics | Waters Corporation (NYSE: WAT) | Thermometric AB (Sweden) |
| Thermometric products are complementary to Water's leading position in thermal analysis, liquid chromatography and mass spectrometry. Deal price more... | ||
| Distribution | AmerisourceBergen Corporation (NYSE:ABC) | Rep-Pharm Inc. |
| Makes AmerisourceBergen's Canadian business over US$1.4 billion in annualized sales and achieves #2 position in that market. Rep-Pharm's more... | ||
| Medical Devices | Cordis Corporation | Ensure Medical |
| Expands Cordis' presence on the West Coast, adds nitinol devices and bioabsorbable vascular wound closure technology. Terms not more... | ||
| Medical Devices | FoxHollow Technologies (NASDAQ: FOXH ) | Kerberos Proximal Solutions, Inc. |
| Kerberos' Thrombectomy aspiration device will expand FoxHollow's product line to combat arterial disease and will be sold via FoxHollow's more... | ||
| Medical Devices | HealthpointCapital, LLC | BioHorizons Implant Systems, Inc. |
| Together with its acquisition of DTI (large dental lab), buying BioHorizons deepens Healthpoint's position within fast growing dental markets. more... | ||
| Medical Devices | Hologic (NASDAQ:HOLX) | R2 Technology |
| The acquisition of R2's computer-aided detection technology follows Hologic's recent acquisition of Suros Surgical. Deal Price - $220m, more... | ||
| Medical Devices | Hologic, Inc. (NASDAQ: HOLX) | Suros Surgical Systems, Inc. |
| Strengthens Hologic's capabilities in women's healthcare and offers a wide portfolio of product offerings in breast cancer detection. Deal more... | ||
| Medical Devices | MIV Therapeutics (OTCBB:MIV; FWB:MIV) | Vascore Medical (Suzhou) Co., Ltd. |
| Combines MIVT's biocompatible HAp stent coatings with Vascore's field-tested stent business and manufacturing operations to create a presence more... | ||
| Medical Devices | Moog Inc. (NYSE: MOG.A) | McKinley Medical Corporation |
| After the Curlin acquisition, buying McKinley expands Moogs's presence in proprietary ambulatory infusion pumps. Deal price - $15m on McKinley more... | ||
| Medical Devices | Natus Medical Incorporated (NASDAQ: BABY) | DELTAMED SA and its wholly owned subsidiary, IT-Med |
| Increases Natus' international growth by broadening its product offerings and leveraging its distribution organization to give it a stronger more... | ||
| Medical Devices | Nonin Medical, Inc. | MedAir AB |
| Strengthens Nonin's market position in physiologic monitoring by adding carbon dioxide monitoring. Terms not more... | ||
| Medical Devices | OccuLogix, Inc. (NASDAQ:RHEO ) | SOLX, Inc. |
| Expands Occulogix's focus to include the treatment of other age-related eye diseases like glaucoma. Deal value - $7m cash, plus stock plus $10m more... | ||
| Medical Devices | Orthofix International N.V. | Blackstone Medical, Inc. |
| Establishes new platform of spinal implant products to market through Orthofix's distribution channels, together with its non-invasive spinal more... | ||
| Medical Devices | RoundTable Healthcare Partners | Aspen Surgical Products, Inc. |
| RoundTable acquired a majority interest in Aspen -- will provide resources and expertise for Aspen to expand its portfolio of OR disposable surgical more... | ||
| Medical Devices | S&T Medical Technolgies, Inc. | B&B Medical Technologies, Inc. |
| An opportunistic acquisition, with expansion potential. The Walden Group inititiated the Deal. Terms not more... | ||
| Medical Devices | Smith & Nephew's Endoscopy division (NYSE: SNN ; LSE: SN ) | OsteoBiologics, Inc. |
| Complements Smith & Nephew's knee repair and arthroscopy lines. Deal value - $72.3m cash (22x sales of more... | ||
| Medical Devices | Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) | Early Cancer Detection Product Line From Lifeline Biotechnologies, Inc. |
| Enhances Solos' position in the women's endoscopic healthcare market by adding early cancer detection product line to its growing line of more... | ||
| Medical Devices | Spacelabs Healthcare, Inc. | Del Mar Reynolds Inc., the Cardiac Division of Ferraris Group plc |
| Expands Spacelab's product portfolio in the hospital market, strengthens its geographic presence in UK and German markets and doubles the more... | ||
| Medical Devices | Theragenics Corporation® (NYSE: TGX) | Galt Medical Corporation |
| Combined with the '05 acquisition of CP Medical, Thergenics continues its diversification strategy. Deal value - $31.9m on estimated sales of more... | ||
| Medical Devices | U.S. Surgical, a unit of Tyco Healthcare (NYSE: TYC; BSX: TYC) | Confluent Surgical, Inc. |
| Expands U.S. Surgical's suture product portfolio, as well as the Autosuture division's surgical stapler franchise. Confluent's more... | ||
| Medical Devices | Viasys Healthcare Inc. (NYSE:VAS) | Tiara Medical Systems, Inc. |
| Expands VIASYS' presence in the sleep therapy market by adding products for treatment of Obstructive Sleep Apnea (OSA) and other chronic more... | ||
| Medical Devices | W.L. Gore & Associates Inc. | Neural Intervention Technologies, Inc. |
| Expands Gore's offerings by products that address hemorrhagic strokes. Terms not more... | ||
| Medical Services | Bain Capital, Kohlberg Kravis Roberts & Co., and Merrill Lynch Global Private Equity | HCA, Inc. (NYSE: HCA) |
| A $33 billion LBO with approximately $32b of total debt -- a landmark deal in size and ambitiousness, requiring major streamlining and efficiencies more... | ||
| Medical Services | Hanger Orthopedic Group, Inc. (NYSE: HGR ) | Regional Artificial Limb & Brace Company, Inc. |
| Strengthens Hanger's O&P market position in the Midwest. Now owns 621 patient care centers in 46 states. Terms not more... | ||
| Medical Services | Hanger Orthopedic Group, Inc. (NYSE: HGR) | Temple Medical, Inc. |
| Furthers Hanger's consolidation of O&P provider market. Terms not more... | ||
| Medical Services | HealthSouth Corporation (OTC Pink Sheets: HLSH) | Hurrle Orthopaedic Physical Therapy, P.C. |
| Adds seven outpatient physical therapy facilities in the Indianapolis, Ind. area. Terms not more... | ||
| Medical Services | PRA International (NASDAQ: PRAI) | Pharma Bio-Research |
| Provides early phase development platform in Europe consisting of 140 beds as well as a state-of-the-art bioanalytical lab facility. Combined with more... | ||
| Medical Services | Reflect Scientific, Inc. (OTCBB:RSCF) | All Temp Engineering |
| Complements RSI's recent acquisition of Cryometrix by integrating ATE intellectual property and engineering capabilities to support worldwide more... | ||
| Medical Services | Vestar Capital Partners | MediMedia USA |
| More aggressive expansion -- organic and acquisitive -- is planned. MediMedia is the core of a broader package of 4 healthcare and business more... | ||
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. | ||